analyzing-shareholder-activism
Tracks activist investor campaigns with thesis analysis and outcome assessment. Use when monitoring activist situations, analyzing proxy fights, or evaluating activist theses.
Best use case
analyzing-shareholder-activism is best used when you need a repeatable AI agent workflow instead of a one-off prompt.
Tracks activist investor campaigns with thesis analysis and outcome assessment. Use when monitoring activist situations, analyzing proxy fights, or evaluating activist theses.
Teams using analyzing-shareholder-activism should expect a more consistent output, faster repeated execution, less prompt rewriting.
When to use this skill
- You want a reusable workflow that can be run more than once with consistent structure.
When not to use this skill
- You only need a quick one-off answer and do not need a reusable workflow.
- You cannot install or maintain the underlying files, dependencies, or repository context.
Installation
Claude Code / Cursor / Codex
Manual Installation
- Download SKILL.md from GitHub
- Place it in
.claude/skills/analyzing-shareholder-activism/SKILL.mdinside your project - Restart your AI agent — it will auto-discover the skill
How analyzing-shareholder-activism Compares
| Feature / Agent | analyzing-shareholder-activism | Standard Approach |
|---|---|---|
| Platform Support | Not specified | Limited / Varies |
| Context Awareness | High | Baseline |
| Installation Complexity | Unknown | N/A |
Frequently Asked Questions
What does this skill do?
Tracks activist investor campaigns with thesis analysis and outcome assessment. Use when monitoring activist situations, analyzing proxy fights, or evaluating activist theses.
Where can I find the source code?
You can find the source code on GitHub using the link provided at the top of the page.
SKILL.md Source
# Analyzing Shareholder Activism ## When To Use - An activist investor (hedge fund, individual, or group) has filed a 13D or 13D/A disclosing a position ≥5% in a public company - A proxy fight, consent solicitation, or board nomination contest is underway or anticipated - Evaluating whether to support management or the activist slate ahead of a shareholder vote - Assessing the investment merit of entering or exiting a position in a company targeted by activists - Reviewing historical activist campaigns at a company or by a specific activist fund for pattern analysis ## Inputs To Gather - **Activist identity and track record**: Fund name, key principals, AUM, historical campaign win rate, typical holding period, and preferred sectors - **13D/13D-A filings**: Ownership stake percentage, acquisition timeline, stated intentions, and any group formations - **Activist thesis materials**: Public letters to the board, white papers, investor presentations, proposed slate bios - **Company fundamentals**: Revenue, EBITDA, margins, capital allocation history, peer multiples, sum-of-parts valuation - **Board and governance profile**: Board composition, tenure, independence ratio, share ownership by directors, classified board status, poison pill provisions, bylaw amendment thresholds [VERIFY against latest proxy statement] - **Proxy advisory firm recommendations**: ISS and Glass Lewis reports if available - **Prior activist history at the target**: Previous campaigns, settlements, board seats gained, operational or strategic changes implemented ## Workflow 1. **Map the activist's position and timeline** - Extract ownership percentage, cost basis (if disclosed), and accumulation pattern from 13D filing history - Identify whether the activist is acting alone or as part of a group (Item 2 of Schedule 13D) - Note any derivative positions (swaps, options) that supplement economic exposure 2. **Deconstruct the activist thesis** - Categorize the campaign type: operational improvement, capital return, strategic alternatives (M&A/spin-off/divestiture), governance reform, or management change - Quantify the activist's value creation claims — compare proposed margin targets, capital allocation changes, or valuation re-rating to current baseline - Stress-test key assumptions: Are margin targets realistic vs. peers? Is the proposed buyback/dividend funded? Does a breakup valuation hold under standalone cost structures? 3. **Assess company defenses and response** - Review defensive provisions: staggered board, advance notice bylaws, supermajority requirements, rights plan (poison pill) status [VERIFY — these vary by state of incorporation] - Evaluate management's public response and any preemptive operational changes (e.g., new buyback, cost initiative, strategic review announcement) - Gauge board willingness to settle vs. fight based on prior behavior and director profiles 4. **Evaluate proxy fight mechanics (if applicable)** - Determine the vote standard: majority vs. plurality, broker non-vote implications [VERIFY against company bylaws and exchange rules] - Analyze the shareholder base: institutional vs. retail mix, index fund holdings (which tend to follow ISS/Glass Lewis), known activist-friendly holders - Estimate vote outcome probability based on proxy advisory recommendations and shareholder composition 5. **Score the campaign and investment implications** - Assign a probability-weighted outcome assessment: full activist victory, partial settlement (board seats, operational concessions), or management prevails - Model upside/downside scenarios tied to each outcome — include timeline to value realization - Identify catalysts and signposts: proxy filing deadlines, annual meeting date, settlement negotiation windows, 13D amendment signals ## Output Produce a structured **Activist Campaign Analysis Report** containing: - **Campaign summary**: One-paragraph overview of activist, target, stake, thesis, and current status - **Thesis breakdown table**: Activist's proposed actions, quantified impact claims, and analyst assessment of feasibility (High / Medium / Low) - **Defense posture assessment**: Governance provisions, management response quality, and settlement likelihood - **Vote probability matrix** (if proxy fight is live): Estimated vote by shareholder category with sensitivity to ISS/Glass Lewis recommendations - **Investment conclusion**: Probability-weighted price target range, recommended position sizing or action (enter, hold, exit, hedge), and key risk factors - **Timeline of key dates**: 13D filing date, nomination deadline, annual meeting date, settlement windows ## Quality Checks - Confirm all ownership percentages and filing dates against SEC EDGAR source documents - Verify governance provisions (board classification, poison pill, bylaw thresholds) against the most recent proxy statement and charter — these change frequently [VERIFY] - Cross-check activist track record claims against actual outcomes from prior campaigns - Ensure valuation assumptions (multiples, margins, cost of capital) are sourced and defensible against peer data - Flag any material non-public information concerns — analysis must rely exclusively on public filings and disclosures - Confirm that vote standard and shareholder base composition reflect the specific company's bylaws and most recent institutional ownership filings (13F data)
Related Skills
analyzing-vital-statistics
Structures vital records analysis with birth, death, and demographic trend reporting. Use when analyzing vital statistics, interpreting mortality data, or reporting demographic trends.
analyzing-social-determinants-of-health
Maps social determinants affecting health outcomes with intervention strategy development. Use when analyzing SDOH, mapping community resources, or designing social health interventions.
analyzing-pharmacovigilance-data
Structures post-marketing safety surveillance with signal detection and PSUR reporting. Use when analyzing safety signals, preparing PSURs, or managing pharmacovigilance data.
analyzing-flow-cytometry
Interprets flow cytometry panels for hematologic malignancy classification and minimal residual disease. Use when analyzing flow cytometry, classifying lymphomas/leukemias, or documenting immunophenotyping.
analyzing-epidemiological-data
Structures epidemiologic analysis with incidence, prevalence, rate calculations, and statistical inference. Use when calculating disease rates, analyzing epi data, or interpreting population statistics.
analyzing-clinical-trial-data
Structures clinical trial data analysis with primary endpoint evaluation and safety reporting. Use when analyzing trial results, evaluating endpoints, or preparing statistical reports.
analyzing-clinical-data-warehouses
Structures clinical data warehouse queries for quality measurement, research, and operational analytics. Use when querying clinical data, building analytics reports, or extracting research datasets.
shareholders-meeting-minutes
Drafts minute-book-ready U.S. corporate shareholders meeting minutes covering notice, record date, quorum, attendance, reports, votes, and resolutions. Use for annual or special shareholders meetings, director elections, auditor ratification, and shareholder proposals. Triggers: "shareholders meeting minutes", "annual meeting minutes", "special meeting minutes", "quorum", "record date", "proxy", "election of directors", "ratify auditors".
shareholder-rights-plan
Drafts a U.S. shareholder rights plan (poison pill) package including rights agreement, certificate of designations, board memo, Form 8-K, and press release. Applies Unocal/Revlon fiduciary framing, Rule 13d-3 beneficial ownership, flip-in/flip-over economics, and redemption/exchange mechanics. Use when a board addresses a hostile bid, activist accumulation, or plan renewal. Trigger: "poison pill", "rights plan", "rights agreement", "flip-in", "flip-over", "DGCL 203", "Unocal", "Revlon".
shareholder-resolution-to-dissolve
Drafts a shareholder resolution authorizing voluntary dissolution of a corporation with state-specific compliance, voting documentation, recitals, winding-up authorizations, and certification. Use when shareholders formally approve voluntary dissolution, corporate wind-down, or entity liquidation.
shareholder-meeting-summary
Generates structured, record-quality summaries of shareholder meetings from minutes, transcripts, and related materials. Triggers when the user provides shareholder meeting documents and requests a summary, minute-book entry, or governance record covering metadata, resolutions, voting outcomes, and dissents.
shareholder-agreement
Drafts U.S. shareholder agreements governing ownership, control, transfers, valuation, and exits with enforceable governance and dispute frameworks. Use when drafting or updating shareholder/stockholder agreements, ROFR and buy-sell terms, drag-along/tag-along rights, founder vesting, or closely held governance. Trigger keywords: shareholder agreement, stockholder agreement, ROFR, tag-along, drag-along, buy-sell, cap table, founder vesting.